Printer Friendly
The Free Library
5,677,469 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Advanced Cell Technology Executives to Present Keynote Address and Company Presentation at New York Society of Security Analysts (NYSSA) Conference.


ALAMEDA, Calif. -- Advanced Cell Technology, Inc.'s (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
: ACTC ACTC Apple Certified Technical Coordinator
ACTC Almaden Cycle Touring Club
ACTC Associated Colleges of the Twin Cities
ACTC All Ceylon Tamil Congress (Sri Lanka)
ACTC Association Canadienne de Télévision par Câble
) Michael West Michael West may refer to:
  • Dr. Michael Philip West, ESL teacher and researcher
  • Dr. Michael D. West, gerontologist and CEO of BioTime, Inc., former Chairman of the Board and Chief Scientific Officer of Advanced Cell Technology, and former CEO of Geron Corporation
 Ph.D., President and Chief Scientific Officer, will deliver the keynote luncheon speech at the New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 Society of Security Analysts Conference (NYSSA Nyssa (nĭs`ə), name of several ancient cities devoted to the worship of Dionysus. The best known of them is a town of Cappadocia, Asia Minor, near the Halys (now the Kizil Irmak) River. It was the residence of St. Gregory of Nyssa. ), on December 12, 2006 at 12:30 PM. William M. Caldwell, IV, Chief Executive Officer, will deliver the company presentation on December 13, 2006 at 1:40 PM. The conference is being held at the NYSSA headquarters located at 1177 Sixth Avenue in New York.

Widely regarded as a leader in the field, prior to founding ACTC, Dr. West organized and managed the research between Geron Corporation (Nasdaq: GERN v. t. 1. To grin or yawn. ) and its academic collaborators, James Thomson and John Gearhart, that led to the first isolation of human embryonic stem and human embryonic germ cells. Dr. West will be speaking on the "Emerging Field of Stem Cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young ".

William Caldwell will be delivering the company presentation, highlighting Advanced Cell's leadership and advancement in the stem cell stem cell

In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult.
 field. The company recently published a paper in Nature regarding the use of embryonic stem cells to rescue visual function in animals, and in August announced an approach to generate human embryonic stem cells that does not destroy the embryo.

A downloadable copy of both presentations will be archived on the company's website the day of the conference, at www.advancedcell.com/conference-presentations/.

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information about the company, please visit http://www.advancedcell.com.

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended September 30, 2006.

Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 11, 2006
Words:491
Previous Article:Sale of Commemorative '32 Roadster to Benefit JDRF at the 36th Annual Barrett-Jackson Auction.
Next Article:Availigent to Integrate Its Duration(R) Software with XenSource's XenEnterprise(TM).
Topics:



Related Articles
NYSSA Presents The New Era of Telecom.
NYSSA Presents 2nd Annual Quebec Biotechnology Industry Conference.
Vulcan to Present at the New York Society of Security Analysts (NYSSA) Construction Materials Conference.
BPZ Energy to Present at New York Society of Security Analysts 9th Annual Energy Conference.
The Bancorp, Inc. to Present at the 6th Annual New York Society of Security Analysts Banking Conference.
Wave to Present at The New York Society of Security Analysts' "Small Cap Innovators" Conference, Thurs., October 5th at 3:50 p.m.
NYSSA Presents 10th Annual Biotech/Specialty Pharma Conference.
CytRx to Present at NYSSA 10th Annual Biotech & Specialty Pharmaceutical Conference.
Dr. George Gorodeski to Speak at NYSSA Medical Equipment & Supplies Conference.
NYSSA Presents 17th Annual High Yield Bond Conference.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles